ArticleBMC cancer2026
CXCR6 and its correlated G protein-coupled receptors and PI3K-AKT pathways were associated with the progression of thyroid cancer.
Article in BMC cancer, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
9 authors.
Funding
Abstract
backgroundImmunogenic cell death (ICD) is closely linked to thyroid cancer (THCA). We mined ICD-linked prognostic genes for survival predictors and unpacked their potential biology. MATERIALS: Single-cell analysis was conducted to identify distinct cell types, and the scores of ICD-related genes (ICDRGs) were computed to identify key cell types. Furthermore, correlation, differential expression, and Kaplan-Meier survival studies were conducted to discover prognostic genes. By employing these genes alongside 101 combinations of 10 algorithms, we constructed a prognostic model and computed risk scores for THCA samples, analyzing their survival disparities. Control and THCA tissue samples were taken to assess the expression of prognostic genes via real-time reverse transcriptase-polymerase chain reaction (RT-qPCR), resulting in the identification of a key gene. Subsequently, gene set enrichment analysis was executed on this key gene, and Western blot analysis was undertaken to evaluate the expression of relevant pathways.
resultsSingle-cell and transcriptome analysis found CXCR6, ICOS, SLAMF7, CD80, and TNF as prognostic genes associated with ICD in THCA. Of the 101 combinations evaluated, the StepCox[both] + Random Survival Forest (RSF) model was selected as the prognostic model owing to its superior C-index. This model accurately forecasted survival outcomes for THCA samples. Expression study demonstrated a notable decrease of CXCR6 in THCA samples, consistent with bioinformatics analysis and it was designated as the key gene. Functional analysis revealed an enrichment of the inflammatory response, accompanied by reduced levels of its principal targets (Gαi) and downstream pathways (Src and PI3K-AKT) in THCA samples.
conclusionThis study found five prognostic genes, with CXCR6 associated with Gαi, Src, and PI3K-AKT pathways in the modulation of THCA, indicating the essential function of CXCR6 in THCA.
Indexed as
Identifiers
What Socratic holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.